While both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have released guidance on the ...

While Quantum computing has been reported to be five years away for many years now, companies are preparing for it by setting ...

When it comes to training artificial intelligence, OpenAI and Babylon Biosciences have shown that experienced hands can help ...

One of the most notable trends highlighted in the study is the shift toward lightweight AI models optimized for execution in ...

A great example is AI. There is no limit to how you could use generative AI in clinical research, but a lot of it is not necessarily going to meet the needs of our customers. Our core customers at ...

Mental health services around the world are stretched thinner than ever. Long wait times, barriers to accessing care and ...

New York, USA, May 07, 2025 (GLOBE NEWSWIRE) -- Global AI in Clinical Trials Market to Show Tremendous Growth at a CAGR of ~12% by 2032 | DelveInsight The demand for AI in clinical trials is ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

Praneeth Reddy Sudalagunta, PhD, discusses a novel generative artificial intelligence pipeline developed to help with the understanding and treatment of multiple myeloma.

The demand for AI in clinical trials is experiencing strong growth, primarily fueled by the rising global prevalence of chronic illnesses like diabet ...